Explore the detailed record of transactions filed by Allan Jonathan. Insider active across 1 company, notably Stoke Therapeutics, Inc.. In total, 28 disclosures have been published. Split: 0 buy · 16 sells. Total volume traded: €1.3m. Activity tracked since 21 June 2023. The latest transaction was filed on 14 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Allan Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Allan Jonathan is a declarant linked to Stoke Therapeutics, Inc. (XNAS), where his primary role is GENERAL COUNSEL & CORP SEC. He has 25 filings in total, and among the 25 most recent sampled filings, the transactions are sales for EUR 1182167 between 2023-06-23 and 2026-06-18.